Karen M Cichowski

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Douglas Adam Rubinson · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
2. Srivatsan Raghavan · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
3. Naiara Perurena · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
4. William C. Hahn · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
5. Andrew J. Aguirre · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
6. Brian Matthew Wolpin · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
7. Jennifer P. Morton · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
8. Owen James Sansom · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
9. James M. Cleary · 1 shared paper, 2023 · strength 0.14
   • Paper USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable ther… DOI 10.1016/j.xcrm.2023.101007↗
10. João A. Paulo · 1 shared paper, 2019 · strength 0.06
    • Paper Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer. DOI 10.1038/s41588-019-0475-y↗
11. Sahar Nissim · 1 shared paper, 2019 · strength 0.06
    • Paper Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer. DOI 10.1038/s41588-019-0475-y↗
12. Alec C. Kimmelman · 1 shared paper, 2019 · strength 0.06
    • Paper Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer. DOI 10.1038/s41588-019-0475-y↗
13. Joseph Douglas Mancias · 1 shared paper, 2019 · strength 0.06
    • Paper Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer. DOI 10.1038/s41588-019-0475-y↗
14. Sapna Syngal · 1 shared paper, 2019 · strength 0.06
    • Paper Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer. DOI 10.1038/s41588-019-0475-y↗
15. Wolfram Goessling · 1 shared paper, 2019 · strength 0.06
    • Paper Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer. DOI 10.1038/s41588-019-0475-y↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.